
PharmaResearch's CTC Bio Acquisition: Strategic Restructuring for Healthcare Transformation
CTC Bio, now under PharmaResearch's control, is undergoing major restructuring by liquidating loss-making subsidiaries and focusing on high-value healthcare business to achieve profitability turnaround.